Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study.
Journal
International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
15
11
2021
accepted:
06
04
2022
revised:
05
04
2022
pubmed:
28
4
2022
medline:
1
7
2022
entrez:
27
4
2022
Statut:
ppublish
Résumé
The association between vitamin D and DSPN has been investigated in cross-sectional studies in individuals with diabetes. However, evidence from prospective and population-based studies is still lacking. Also, the potential modifying effect of obesity and glucose tolerance has not been investigated. Therefore, we examined the cross-sectional and prospective associations of serum 25(OH)D with DSPN and assessed possible effect modifications. The study included individuals aged 62-81 years who participated in the German KORA F4 (2006-2008) and FF4 (2013-2014) studies. DSPN was assessed using the Michigan Neuropathy Screening Instrument. Cross-sectional analyses (n = 1065; 33% of the participants had obesity) assessed the associations of baseline 25(OH)D with prevalent DSPN, while prospective analyses (n = 422) assessed the associations of 25(OH)D with incident DSPN. No association was found between 25(OH)D and prevalent DSPN in the total sample after adjustment for age, sex, season of blood sampling, BMI, metabolic variables, lifestyle factors, and comorbidities. However, a decrease by 10 nmol/L in 25(OH)D was associated with prevalent DSPN (RR (95% CI) 1.08 (1.01, 1.16)) in individuals with obesity but not in normal-weight individuals (RR (95% CI) 0.97 (0.92, 1.02), p Our study did not show consistent evidence for cross-sectional and prospective associations between serum 25(OH)D levels and DSPN in the total study population of older individuals. However, there was evidence for an association between lower serum 25(OH)D levels and higher prevalence of DSPN in individuals with obesity.
Sections du résumé
BACKGROUND/OBJECTIVES
The association between vitamin D and DSPN has been investigated in cross-sectional studies in individuals with diabetes. However, evidence from prospective and population-based studies is still lacking. Also, the potential modifying effect of obesity and glucose tolerance has not been investigated. Therefore, we examined the cross-sectional and prospective associations of serum 25(OH)D with DSPN and assessed possible effect modifications.
SUBJECTS/METHODS
The study included individuals aged 62-81 years who participated in the German KORA F4 (2006-2008) and FF4 (2013-2014) studies. DSPN was assessed using the Michigan Neuropathy Screening Instrument. Cross-sectional analyses (n = 1065; 33% of the participants had obesity) assessed the associations of baseline 25(OH)D with prevalent DSPN, while prospective analyses (n = 422) assessed the associations of 25(OH)D with incident DSPN.
RESULTS
No association was found between 25(OH)D and prevalent DSPN in the total sample after adjustment for age, sex, season of blood sampling, BMI, metabolic variables, lifestyle factors, and comorbidities. However, a decrease by 10 nmol/L in 25(OH)D was associated with prevalent DSPN (RR (95% CI) 1.08 (1.01, 1.16)) in individuals with obesity but not in normal-weight individuals (RR (95% CI) 0.97 (0.92, 1.02), p
CONCLUSIONS
Our study did not show consistent evidence for cross-sectional and prospective associations between serum 25(OH)D levels and DSPN in the total study population of older individuals. However, there was evidence for an association between lower serum 25(OH)D levels and higher prevalence of DSPN in individuals with obesity.
Identifiants
pubmed: 35474356
doi: 10.1038/s41366-022-01122-2
pii: 10.1038/s41366-022-01122-2
pmc: PMC9239908
doi:
Substances chimiques
Vitamin D
1406-16-2
25-hydroxyvitamin D
A288AR3C9H
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1366-1374Informations de copyright
© 2022. The Author(s).
Références
Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the american diabetes association. Diabetes Care. 2017;40:136–54.
pubmed: 27999003
doi: 10.2337/dc16-2042
Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol. 2011;7:682–90.
pubmed: 21750507
doi: 10.1038/nrendo.2011.113
Herder C, Roden M, Ziegler D. Novel insights into sensorimotor and cardiovascular autonomic neuropathy from recent-onset diabetes and population-based cohorts. Trends Endocrinol Metab. 2019;30:286–98.
pubmed: 30935671
doi: 10.1016/j.tem.2019.02.007
Schlesinger S, Herder C, Kannenberg JM, Huth C, Carstensen-Kirberg M, Rathmann W, et al. General and abdominal obesity and incident distal sensorimotor polyneuropathy: insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 Cohort. Diabetes Care. 2019;42:240–7.
pubmed: 30523031
doi: 10.2337/dc18-1842
Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, et al. Risk factors for incident diabetic polyneuropathy in a cohort With screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care. 2018;41:1068–75.
pubmed: 29487078
doi: 10.2337/dc17-2062
Girach A, Julian TH, Varrassi G, Paladini A, Vadalouka A, Zis P. Quality of life in painful peripheral neuropathies: a systematic review. Pain Res Manag. 2019;2019:2091960.
pubmed: 31249636
pmcid: 6556282
doi: 10.1155/2019/2091960
Mason RS, Sequeira VB, Gordon-Thomson C. Vitamin D: the light side of sunshine. Eur J Clin Nutr. 2011;65:986–93.
pubmed: 21731037
doi: 10.1038/ejcn.2011.105
Wrzosek M, Łukaszkiewicz J, Wrzosek M, Jakubczyk A, Matsumoto H, Piątkiewicz P, et al. Vitamin D and the central nervous system. Pharmacol Rep. 2013;65:271–8.
pubmed: 23744412
doi: 10.1016/S1734-1140(13)71003-X
Putz Z, Martos T, Németh N, Körei AE, Vági OE, Kempler MS, et al. Is there an association between diabetic neuropathy and low vitamin D levels? Curr Diab Rep. 2014;14:537.
pubmed: 25142719
doi: 10.1007/s11892-014-0537-6
Agholme L, Lindstrom T, Kagedal K, Marcusson J, Hallbeck M. An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis. 2010;20:1069–82.
pubmed: 20413890
doi: 10.3233/JAD-2010-091363
Bianchi VE, Locatelli V, Rizzi L. Neurotrophic and Neuroregenerative Effects of GH/IGF1. Int J Mol Sci. 2017;18:2441.
Cornet A, Baudet C, Neveu I, Baron-Van Evercooren A, Brachet P, Naveilhan P. 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res. 1998;53:742–6.
pubmed: 9753201
doi: 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#
Chabas JF, Stephan D, Marqueste T, Garcia S, Lavaut MN, Nguyen C, et al. Cholecalciferol (vitamin D(3)) improves myelination and recovery after nerve injury. PLoS ONE. 2013;8:e65034.
pubmed: 23741446
pmcid: 3669361
doi: 10.1371/journal.pone.0065034
Lucato P, Solmi M, Maggi S, Bertocco A, Bano G, Trevisan C, et al. Low vitamin D levels increase the risk of type 2 diabetes in older adults: a systematic review and meta-analysis. Maturitas. 2017;100:8–15.
pubmed: 28539181
doi: 10.1016/j.maturitas.2017.02.016
Soderstrom LH, Johnson SP, Diaz VA, Mainous AG 3rd. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001-2004 NHANES. Diabet Med. 2012;29:50–5.
pubmed: 21726279
pmcid: 3461835
doi: 10.1111/j.1464-5491.2011.03379.x
Niu Y, Li J, Peng R, Zhao X, Wu J, Tang Q. Low vitamin D is associated with diabetes peripheral neuropathy in older but not in young and middle-aged patients. Diabetes Metab Res Rev. 2019;35:e3162.
pubmed: 30931541
doi: 10.1002/dmrr.3162
Ozuguz U, Oruc S, Ulu MS, Demirbas H, Acay A, Coker B, et al. Does vitamin D have any role in the improvement of diabetic peripheral neuropathy in type 1 diabetic patients? J Endocrinol Investig. 2016;39:1411–7.
doi: 10.1007/s40618-016-0509-6
Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA. Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? Diabet Med. 2012;29:43–9.
pubmed: 22050401
doi: 10.1111/j.1464-5491.2011.03510.x
Alam U, Petropoulos IN, Ponirakis G, Ferdousi M, Asghar O, Jeziorska M, et al. Vitamin D deficiency is associated with painful diabetic neuropathy. Diabetes Metab Res Rev. 2021;37:e3361.
pubmed: 32506740
doi: 10.1002/dmrr.3361
Skalli S, Muller M, Pradines S, Halimi S, Wion-Barbot N. Vitamin D deficiency and peripheral diabetic neuropathy. Eur J Intern Med. 2012;23:e67–8.
pubmed: 22284260
doi: 10.1016/j.ejim.2011.11.008
He R, Hu Y, Zeng H, Zhao J, Zhao J, Chai Y, et al. Vitamin D deficiency increases the risk of peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetes Metab Res Rev. 2017;33:e2820.
Alamdari A, Mozafari R, Tafakhori A, Faghihi-Kashani S, Hafezi-Nejad N, Sheikhbahaei S, et al. An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects. Neurol Sci. 2015;36:1121–6.
pubmed: 25851730
doi: 10.1007/s10072-015-2207-0
Abdelsadek SE, El Saghier EO, Abdel Raheem SI. Serum 25(OH) vitamin D level and its relation to diabetic peripheral neuropathy in Egyptian patients with type 2 diabetes mellitus. Egypt J Neurol Psychiatr Neurosurg. 2018;54:36.
pubmed: 30532515
pmcid: 6245139
doi: 10.1186/s41983-018-0036-9
Fan L, Zhang Y, Zhu J, Song Y, Lin J. Association of vitamin D deficiency with diabetic peripheral neuropathy and diabetic nephropathy in Tianjin, China. Asia Pac J Clin Nutr. 2018;27:599–606.
pubmed: 29737807
Zambelis T, Papadakis G, Kokotis P, Villiotou V, Dogkas N, Karandreas N. Lack of definite association of vitamin d deficiency with diabetic neuropathy. Investigation in Greek and in Bangladeshi patients. In Vivo. 2017;31:259–61.
pubmed: 28358709
pmcid: 5411754
doi: 10.21873/invivo.11054
Shillo P, Selvarajah D, Greig M, Gandhi R, Rao G, Wilkinson ID, et al. Reduced vitamin D levels in painful diabetic peripheral neuropathy. Diabet Med. 2019;36:44–51.
pubmed: 30102801
doi: 10.1111/dme.13798
Lv WS, Zhao WJ, Gong SL, Fang DD, Wang B, Fu ZJ, et al. Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. J Endocrinol Invest. 2015;38:513–8.
pubmed: 25527161
doi: 10.1007/s40618-014-0210-6
Qu GB, Wang LL, Tang X, Wu W, Sun YH. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: An update systematic review and meta-analysis. J Clin Transl Endocrinol. 2017;9:25–31.
pubmed: 29067266
pmcid: 5651294
Dai J, Jiang C, Chen H, Chai Y. Vitamin D and diabetic foot ulcer: a systematic review and meta-analysis. Nutr Diabetes. 2019;9:8.
pubmed: 30858355
pmcid: 6411880
doi: 10.1038/s41387-019-0078-9
Yammine K, Hayek F, Assi C. Is there an association between vitamin D and diabetic foot disease? A meta-analysis. Wound Repair Regen. 2020;28:90–6.
pubmed: 31633861
doi: 10.1111/wrr.12762
Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10:e1001383.
pubmed: 23393431
pmcid: 3564800
doi: 10.1371/journal.pmed.1001383
Herder C, Schneider A, Zhang S, Wolf K, Maalmi H, Huth C, et al. Association of long-term air pollution with prevalence and incidence of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Environ Health Perspect. 2020;128:127013.
pubmed: 33356516
pmcid: 7757787
doi: 10.1289/EHP7311
Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–9.
pubmed: 7821168
doi: 10.2337/diacare.17.11.1281
Martina IS, van Koningsveld R, Schmitz PI, van der Meché FG, van Doorn PA. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. J Neurol Neurosurg Psychiatry. 1998;65:743–7.
pubmed: 9810949
pmcid: 2170371
doi: 10.1136/jnnp.65.5.743
Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, et al. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care. 2009;32:680–2.
pubmed: 19131463
pmcid: 2660451
doi: 10.2337/dc08-2011
Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.
pubmed: 20876709
pmcid: 2945176
doi: 10.2337/dc10-1303
Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002;162:2074–9.
pubmed: 12374515
doi: 10.1001/archinte.162.18.2074
Herder C, Kannenberg JM, Niersmann C, Huth C, Carstensen-Kirberg M, Wittenbecher C, et al. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. Eur J Endocrinol. 2017;177:277–86.
pubmed: 28679518
doi: 10.1530/EJE-17-0100
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–9.
pubmed: 22762315
pmcid: 4398023
doi: 10.1056/NEJMoa1114248
Herder C, Kannenberg JM, Carstensen-Kirberg M, Strom A, Bonhof GJ, Rathmann W, et al. A systemic inflammatory signature reflecting cross talk between innate and adaptive immunity is associated with incident polyneuropathy: KORA F4/FF4 Study. Diabetes. 2018;67:2434–42.
pubmed: 30115651
doi: 10.2337/db18-0060
Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–57.
pubmed: 20087875
Lee CC, Perkins BA, Kayaniyil S, Harris SB, Retnakaran R, Gerstein HC, et al. Peripheral neuropathy and nerve dysfunction in individuals at high risk for Type 2 diabetes: The PROMISE Cohort. Diabetes Care. 2015;38:793–800.
pubmed: 25665810
doi: 10.2337/dc14-2585
Bejar CA, Goyal S, Afzal S, Mangino M, Zhou A, van der Most PJ, et al. A bidirectional Mendelian Randomization Study to evaluate the causal role of reduced blood vitamin D levels with type 2 diabetes risk in South Asians and Europeans. Nutr J. 2021;20:71.
pubmed: 34315477
pmcid: 8314596
doi: 10.1186/s12937-021-00725-1
Li X, Liu Y, Zheng Y, Wang P, Zhang Y. The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients. 2018;10:375.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–3.
pubmed: 10966885
doi: 10.1093/ajcn/72.3.690
Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20:1444–8.
doi: 10.1038/oby.2011.404
Roizen JD, Long C, Casella A, O’Lear L, Caplan I, Lai M, et al. Obesity decreases hepatic 25-hydroxylase activity causing low serum 25-hydroxyvitamin D. J Bone Miner Res. 2019;34:1068–73.
pubmed: 30790351
doi: 10.1002/jbmr.3686
Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab. 2007;92:1023–33.
pubmed: 17164304
doi: 10.1210/jc.2006-1055
Sakai S, Suzuki M, Tashiro Y, Tanaka K, Takeda S, Aizawa K, et al. Vitamin D receptor signaling enhances locomotive ability in mice. J Bone Miner Res. 2015;30:128–36.
pubmed: 25043694
doi: 10.1002/jbmr.2317
Rask CA. Biological actions of nerve growth factor in the peripheral nervous system. Eur Neurol. 1999;41:14–9. Suppl 1
pubmed: 10023124
doi: 10.1159/000052075
Xu S, Li J, Zhai M, Yao X, Liu H, Deng T, et al. 1,25-(OH)(2)D(3) protects Schwann cells against advanced glycation end products-induced apoptosis through PKA-NF-κB pathway. Life Sci. 2019;225:107–16.
pubmed: 30928409
doi: 10.1016/j.lfs.2019.03.068
Xiaohua G, Dongdong L, Xiaoting N, Shuoping C, Feixia S, Huajun Y, et al. Severe vitamin D deficiency is associated with increased expression of inflammatory cytokines in painful diabetic peripheral neuropathy. Front Nutr. 2021;8:612068.
pubmed: 33777989
pmcid: 7987807
doi: 10.3389/fnut.2021.612068
Herder C, Kannenberg JM, Huth C, Carstensen-Kirberg M, Rathmann W, Koenig W, et al. Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Diabetes Care. 2017;40:569–76.
pubmed: 28174259
doi: 10.2337/dc16-2259
Yammine K, Wehbe R, Assi C. A systematic review on the efficacy of vitamin D supplementation on diabetic peripheral neuropathy. Clin Nutr. 2020;39:2970–4.
pubmed: 32089370
doi: 10.1016/j.clnu.2020.01.022
Karonova T, Stepanova A, Bystrova A, Jude EB. High-Dose vitamin D supplementation improves microcirculation and reduces inflammation in diabetic neuropathy patients. Nutrients. 2020;12:2518.
pmcid: 7551635
doi: 10.3390/nu12092518
Ziegler D, Porta M, Papanas N, Mota M, Jermendy G, Beltramo E, et al. The role of biofactors in diabetic microvascular complications. Curr Diabetes Rev. 2022;18:e250821195830.